Health Global Access Project: Activists Critique Johnson & Johnson's Framework for 'Non-Profit' Pricing, Single-Source Manufacturing of COVID-19 Vaccine Candidate
April 24, 2020
April 24, 2020
BROOKLYN, New York, April 24 -- Health Global Access Project issued the following news release:
Johnson & Johnson held its virtual shareholder meeting - the first shareholder meeting of a company with a candidate product since the height of the COVID-19 outbreak.
J&J has made headlines recently with its announcement that it intends to sell its COVID-19 candidate vaccine for $10 or 10 euros a dose and that the product could be ready by early 2021. Activists are c . . .
Johnson & Johnson held its virtual shareholder meeting - the first shareholder meeting of a company with a candidate product since the height of the COVID-19 outbreak.
J&J has made headlines recently with its announcement that it intends to sell its COVID-19 candidate vaccine for $10 or 10 euros a dose and that the product could be ready by early 2021. Activists are c . . .